chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (Arm hot/now it's warmer) and VACCINATION SITE ERYTHEMA (A red spot/nowit's redder) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included AMLODIPINE for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 09-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Arm hot/now it's warmer) and VACCINATION SITE ERYTHEMA (A red spot/nowit's redder). At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (Arm hot/now it's warmer) and VACCINATION SITE ERYTHEMA (A red spot/nowit's redder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pain in extremity
Clinical narrative: Tenderness; Arm pain; Fatigue; Nausea; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 7/Apr/2021) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history).    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness), HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain). At the time of the report, FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness), HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given No treatment information was provided
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Tenderness; Arm pain; Fatigue; Nausea; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 7/Apr/2021) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history).    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness), HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain). At the time of the report, FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness), HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given No treatment information was provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Condition aggravated, Rash macular
Clinical narrative: Red pimples on her forehead; Red pimples around her nose; Red pimples on her chin; Feels like they're worse now; They're reddish; They look like pimples; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ACNE (Red pimples on her forehead), ACNE (Red pimples around her nose), ACNE (Red pimples on her chin), CONDITION AGGRAVATED (Feels like they're worse now) and RASH MACULAR (They're reddish) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 007M2U7) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACNE (Red pimples on her forehead), ACNE (Red pimples around her nose), ACNE (Red pimples on her chin), CONDITION AGGRAVATED (Feels like they're worse now), RASH MACULAR (They're reddish) and ACNE (They look like pimples). At the time of the report, ACNE (Red pimples on her forehead), ACNE (Red pimples around her nose), ACNE (Red pimples on her chin), CONDITION AGGRAVATED (Feels like they're worse now), RASH MACULAR (They're reddish) and ACNE (They look like pimples) outcome was unknown.  Treatment details included Vaselin.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-142531:crosslinked
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test
Clinical narrative: Little sick; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Little sick) and COVID-19 (COVID-19) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MALAISE (Little sick) and COVID-19 (COVID-19). At the time of the report, MALAISE (Little sick) and COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, SARS-CoV-2 test: positive positive Positive.         The concomitant medications were not provided.The treatment information was not provided.  The action taken for mRNA1273 with the events were considered as not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hot flush
Clinical narrative: Hot flashes; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flashes) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HOT FLUSH (Hot flashes) and CHILLS (Chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, HOT FLUSH (Hot flashes) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain
Clinical narrative: left hip and left knee started hurting; injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (left hip and left knee started hurting) and INJECTION SITE PAIN (injection site tenderness) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced ARTHRALGIA (left hip and left knee started hurting) and INJECTION SITE PAIN (injection site tenderness). At the time of the report, ARTHRALGIA (left hip and left knee started hurting) and INJECTION SITE PAIN (injection site tenderness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blister, Herpes zoster, Peripheral swelling, Pruritus
Clinical narrative: shingles; blisters; pain in hip; arm with red spots; arm itching; swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), BLISTER (blisters), PRURITUS (arm itching), PERIPHERAL SWELLING (swollen arm) and ARTHRALGIA (pain in hip) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044I21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 12-Mar-2021, the patient experienced PRURITUS (arm itching), PERIPHERAL SWELLING (swollen arm) and VACCINATION SITE ERYTHEMA (arm with red spots). On 16-Mar-2021, the patient experienced HERPES ZOSTER (shingles), BLISTER (blisters) and ARTHRALGIA (pain in hip). At the time of the report, HERPES ZOSTER (shingles), BLISTER (blisters) and ARTHRALGIA (pain in hip) had not resolved and PRURITUS (arm itching), PERIPHERAL SWELLING (swollen arm) and VACCINATION SITE ERYTHEMA (arm with red spots) had resolved.            Treatment details included Icdalacyclovir hcl 1000mg 3x a day and ice.  .Action taken with mRNA-1273 in response to the event was not applicable.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: shingles; blisters; pain in hip; arm with red spots; arm itching; swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), BLISTER (blisters), PRURITUS (arm itching), PERIPHERAL SWELLING (swollen arm) and ARTHRALGIA (pain in hip) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044I21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 12-Mar-2021, the patient experienced PRURITUS (arm itching), PERIPHERAL SWELLING (swollen arm) and VACCINATION SITE ERYTHEMA (arm with red spots). On 16-Mar-2021, the patient experienced HERPES ZOSTER (shingles), BLISTER (blisters) and ARTHRALGIA (pain in hip). At the time of the report, HERPES ZOSTER (shingles), BLISTER (blisters) and ARTHRALGIA (pain in hip) had not resolved and PRURITUS (arm itching), PERIPHERAL SWELLING (swollen arm) and VACCINATION SITE ERYTHEMA (arm with red spots) had resolved.            Treatment details included Icdalacyclovir hcl 1000mg 3x a day and ice.  .Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Bright Red Mark; Hardness; Warm (red mark); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Bright Red Mark), VACCINATION SITE PAIN (Hardness) and VACCINATION SITE WARMTH (Warm (red mark)) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for an unknown indication.     The patient's past medical history details were not included. Concomittant product usage were also not provided.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ERYTHEMA (Bright Red Mark), VACCINATION SITE PAIN (Hardness) and VACCINATION SITE WARMTH (Warm (red mark)). At the time of the report, ERYTHEMA (Bright Red Mark), VACCINATION SITE PAIN (Hardness) and VACCINATION SITE WARMTH (Warm (red mark)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Urticaria
Clinical narrative: Hives in his left arm and buttocks; Trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives in his left arm and buttocks) and DYSPNOEA (Trouble breathing) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017821A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced URTICARIA (Hives in his left arm and buttocks) and DYSPNOEA (Trouble breathing). At the time of the report, URTICARIA (Hives in his left arm and buttocks) and DYSPNOEA (Trouble breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant product use was reported.  Treatment details included Benadryl and hydrocortisone 1% cream.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia, Rhinorrhoea, Vomiting
Clinical narrative: runny nose; body aches; fever; really really fatigue and usually I have alot of energy; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHEA (runny nose), PAIN (body aches), PYREXIA (fever), FATIGUE (really really fatigue and usually I have alot of energy) and VOMITING (vomiting) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Past medical history not provided). Concomitant products included SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHINORRHEA (runny nose), PAIN (body aches), PYREXIA (fever), FATIGUE (really really fatigue and usually I have alot of energy) and VOMITING ( vomiting ). At the time of the report, RHINORRHOEA (runny nose), PAIN (body aches), PYREXIA (fever), FATIGUE (really really fatigue and usually I have alot of energy) and VOMITING ( vomiting ) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication taken by the patient was  Albuterol HFA inhaler, 2 puffs by mouth three times daily. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Feeling abnormal
Clinical narrative: redness at the injection site; swollen at the injection site; lot of pain at the injection site; diarrhea; headache; fever 39 °C; chills; fatigue; muscular pain; joint pain; felt very bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt very bad), DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (fever 39 °C) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt very bad), HEADACHE (headache), PYREXIA (fever 39 °C), CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscular pain) and ARTHRALGIA (joint pain). On 10-Apr-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE PAIN (lot of pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt very bad), DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (fever 39 °C), CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscular pain), ARTHRALGIA (joint pain), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE PAIN (lot of pain at the injection site) outcome was unknown.            No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: redness at the injection site; swollen at the injection site; lot of pain at the injection site; diarrhea; headache; fever 39 °C; chills; fatigue; muscular pain; joint pain; felt very bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt very bad), DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (fever 39 °C) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt very bad), HEADACHE (headache), PYREXIA (fever 39 °C), CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscular pain) and ARTHRALGIA (joint pain). On 10-Apr-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE PAIN (lot of pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt very bad), DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (fever 39 °C), CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscular pain), ARTHRALGIA (joint pain), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE PAIN (lot of pain at the injection site) outcome was unknown.            No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: redness at the injection site; swollen at the injection site; lot of pain at the injection site; diarrhea; headache; fever 39 °C; chills; fatigue; muscular pain; joint pain; felt very bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt very bad), DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (fever 39 °C) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt very bad), HEADACHE (headache), PYREXIA (fever 39 °C), CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscular pain) and ARTHRALGIA (joint pain). On 10-Apr-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE PAIN (lot of pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt very bad), DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (fever 39 °C), CHILLS (chills), FATIGUE (fatigue), MYALGIA (muscular pain), ARTHRALGIA (joint pain), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swollen at the injection site) and VACCINATION SITE PAIN (lot of pain at the injection site) outcome was unknown.            No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Pain in extremity, Photosensitivity reaction
Clinical narrative: Arm extremely sore; Eyes sensitive to light; Arm extremely sore including her armpit; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm extremely sore), PHOTOSENSITIVITY REACTION (Eyes sensitive to light), AXILLARY PAIN (Arm extremely sore including her armpit) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm extremely sore), PHOTOSENSITIVITY REACTION (Eyes sensitive to light), AXILLARY PAIN (Arm extremely sore including her armpit) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Arm extremely sore), PHOTOSENSITIVITY REACTION (Eyes sensitive to light), AXILLARY PAIN (Arm extremely sore including her armpit) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia
Clinical narrative: Fever; Cold symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and NASOPHARYNGITIS (Cold symptoms) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and NASOPHARYNGITIS (Cold symptoms). At the time of the report, PYREXIA (Fever) and NASOPHARYNGITIS (Cold symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information were not reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Soreness at the Injection site; Redness at injection site that it is 4inch by 6inch; Swelling at injection site that it is 4inch by 6inch; Felt achy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the Injection site), VACCINATION SITE ERYTHEMA (Redness at injection site that it is 4inch by 6inch), VACCINATION SITE SWELLING (Swelling at injection site that it is 4inch by 6inch) and MYALGIA (Felt achy) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (Felt achy). On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at the Injection site), VACCINATION SITE ERYTHEMA (Redness at injection site that it is 4inch by 6inch) and VACCINATION SITE SWELLING (Swelling at injection site that it is 4inch by 6inch). On 06-Apr-2021, MYALGIA (Felt achy) had resolved. At the time of the report, VACCINATION SITE PAIN (Soreness at the Injection site), VACCINATION SITE ERYTHEMA (Redness at injection site that it is 4inch by 6inch) and VACCINATION SITE SWELLING (Swelling at injection site that it is 4inch by 6inch) outcome was unknown.            Concomitant medication list was not reported Treatment information was not reported.   This case was linked to MOD-2021-073334 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: mental fog; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (mental fog) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 012LZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced FEELING ABNORMAL (mental fog). At the time of the report, FEELING ABNORMAL (mental fog) had not resolved.            Treatment medication included motion sickness tablet. No concomitant medication was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Vaccination site pain
Clinical narrative: soreness at the injection site; headaches and dizziness; headaches and dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (headaches and dizziness), HEADACHE (headaches and dizziness) and VACCINATION SITE PAIN (soreness at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045a21a) for COVID-19 vaccination.     Concomitant products included FAMOTIDINE and VENLAFAXINE for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced DIZZINESS (headaches and dizziness) and HEADACHE (headaches and dizziness). On 09-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, DIZZINESS (headaches and dizziness), HEADACHE (headaches and dizziness) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported. Concomitant medication include- iron supplement, vitamins
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Burning mouth syndrome, Facial nerve disorder, Hypoaesthesia oral
Clinical narrative: her mouth felt numb with a little of tin; she could not taste anything; Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue; has burning mouth syndrome; symptoms have to be related to the nerves; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (her mouth felt numb with a little of tin), AGEUSIA (she could not taste anything), HYPOAESTHESIA ORAL (Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue), BURNING MOUTH SYNDROME (has burning mouth syndrome) and FACIAL NERVE DISORDER (symptoms have to be related to the nerves) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Burning mouth syndrome, Sulfonamide allergy and Drug allergy. Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (her mouth felt numb with a little of tin), AGEUSIA (she could not taste anything), HYPOAESTHESIA ORAL (Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue), BURNING MOUTH SYNDROME (has burning mouth syndrome) and FACIAL NERVE DISORDER (symptoms have to be related to the nerves). At the time of the report, HYPOAESTHESIA ORAL (her mouth felt numb with a little of tin), AGEUSIA (she could not taste anything), HYPOAESTHESIA ORAL (Her tongue feels as if it is a burned, numbed tongue. sensation has not returned to her tongue), BURNING MOUTH SYNDROME (has burning mouth syndrome) and FACIAL NERVE DISORDER (symptoms have to be related to the nerves) outcome was unknown.            Vitamin D is used for low blood level.   No treatment was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Patient demographics were updated. Second dose details were added. Concomitant medications were added.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Erythema, Hypersensitivity, Pruritus
Clinical narrative: Has itching all over; Reddish skin all over; Allergic reaction; Very uncomfortable; This spontaneous case was reported by an other health care professional and describes the occurrence of PRURITUS (Has itching all over), ERYTHEMA (Reddish skin all over), HYPERSENSITIVITY (Allergic reaction) and DISCOMFORT (Very uncomfortable) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PRURITUS (Has itching all over), ERYTHEMA (Reddish skin all over), HYPERSENSITIVITY (Allergic reaction) and DISCOMFORT (Very uncomfortable). At the time of the report, PRURITUS (Has itching all over), ERYTHEMA (Reddish skin all over), HYPERSENSITIVITY (Allergic reaction) and DISCOMFORT (Very uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Concomitant medication was not provided. Med Info Agent:  Caller is a  LPN, Multi Skill Tech (MST),HHA, CNA retuning call she received from Moderna and was retuning it. Provided update contact information and gave consent to reach back out.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Non-significant Follow-up appended to AER. : contact information updated and gave consent for further follow-up.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Pain, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy for one day after vaccination), ERYTHEMA (Redness of size 4 inch by 6 inch), VACCINATION SITE PAIN (Soreness and redness of the left arm at site of injection) and INJECTION SITE ERYTHEMA (Soreness and redness of the left arm at site of injection) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Achy for one day after vaccination), ERYTHEMA (Redness of size 4 inch by 6 inch), VACCINATION SITE PAIN (Soreness and redness of the left arm at site of injection) and INJECTION SITE ERYTHEMA (Soreness and redness of the left arm at site of injection). At the time of the report, PAIN (Achy for one day after vaccination), ERYTHEMA (Redness of size 4 inch by 6 inch), VACCINATION SITE PAIN (Soreness and redness of the left arm at site of injection) and INJECTION SITE ERYTHEMA (Soreness and redness of the left arm at site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Nodule
Clinical narrative: Inflammatory nodules; This spontaneous case was reported by a physician and describes the occurrence of NODULE (Inflammatory nodules) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Dermal filler injection (Restylane Lyft.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NODULE (Inflammatory nodules). At the time of the report, NODULE (Inflammatory nodules) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 in response to the event was not applicable.  Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Patient took moderna covid-19 vaccine. case is valid.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Chills, Feeling abnormal, Furuncle, Insomnia
Clinical narrative: Blister or pimple on skin all over the body; He is up all night; Boil; It is getting worse and worse/suffered terribly; chills; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister or pimple on skin all over the body), INSOMNIA (He is up all night), FURUNCLE (Boil), FEELING ABNORMAL (It is getting worse and worse/suffered terribly) and CHILLS (chills) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Chronic obstructive pulmonary disease.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (Blister or pimple on skin all over the body), INSOMNIA (He is up all night), FURUNCLE (Boil), FEELING ABNORMAL (It is getting worse and worse/suffered terribly) and CHILLS (chills). The patient was treated with CALAMINE for Blister, at an unspecified dose and frequency and MAGNESIUM SULFATE (EPSON) for Blister, at a dose of UNK dosage form. At the time of the report, BLISTER (Blister or pimple on skin all over the body), INSOMNIA (He is up all night), FURUNCLE (Boil), FEELING ABNORMAL (It is getting worse and worse/suffered terribly) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported.   This case was linked to MOD-2021-073261 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Added the event (Chills), Second dose of the vaccine. Denied follow up; Sender's Comments: Very limited information regarding these events have been provided at this time. No further information is expected at this time.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Most painful vaccine I have ever received/experienced; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Most painful vaccine I have ever received/experienced) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN (Most painful vaccine I have ever received/experienced). At the time of the report, PAIN (Most painful vaccine I have ever received/experienced) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Fatigue, Lethargy, Myalgia, Nausea
Clinical narrative: pretty serious side effects; Lethargy; severe pain in arm which was swollen up; severe pain in arm which was swollen up / arm was painfull; fever; fatigue; nausea; Arm sore at injection site; This spontaneous case was reported by a patient and describes the occurrence of ADVERSE DRUG REACTION (pretty serious side effects), LETHARGY (Lethargy), PERIPHERAL SWELLING (severe pain in arm which was swollen up), MYALGIA (severe pain in arm which was swollen up / arm was painfull) and PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia in 2009, Hypoglycemia in 1980, Hypothyroidism in 2015, Irritable bowel syndrome in 1980 and Hysterectomy in 1994. Concurrent medical conditions included Allergic reaction to drug, Peanut allergy, Allergy to edible fungus and Allergy to vaccine. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ESTRADIOL for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (pretty serious side effects), LETHARGY (Lethargy), PERIPHERAL SWELLING (severe pain in arm which was swollen up), MYALGIA (severe pain in arm which was swollen up / arm was painfull), PYREXIA (fever), FATIGUE (fatigue), NAUSEA (nausea) and VACCINATION SITE PAIN (Arm sore at injection site). At the time of the report, ADVERSE DRUG REACTION (pretty serious side effects), PERIPHERAL SWELLING (severe pain in arm which was swollen up), MYALGIA (severe pain in arm which was swollen up / arm was painfull), PYREXIA (fever), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient experienced similar kind of adverse events on March 29 2021 and 23 APR 2021 to Tetanus vaccine. Treatment medication include Tylenol which did not help.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant follow-up appended
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vaccination site pain
Clinical narrative: pretty serious side effects; Lethargy; severe pain in arm which was swollen up; severe pain in arm which was swollen up / arm was painfull; fever; fatigue; nausea; Arm sore at injection site; This spontaneous case was reported by a patient and describes the occurrence of ADVERSE DRUG REACTION (pretty serious side effects), LETHARGY (Lethargy), PERIPHERAL SWELLING (severe pain in arm which was swollen up), MYALGIA (severe pain in arm which was swollen up / arm was painfull) and PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fibromyalgia in 2009, Hypoglycemia in 1980, Hypothyroidism in 2015, Irritable bowel syndrome in 1980 and Hysterectomy in 1994. Concurrent medical conditions included Allergic reaction to drug, Peanut allergy, Allergy to edible fungus and Allergy to vaccine. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ESTRADIOL for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (pretty serious side effects), LETHARGY (Lethargy), PERIPHERAL SWELLING (severe pain in arm which was swollen up), MYALGIA (severe pain in arm which was swollen up / arm was painfull), PYREXIA (fever), FATIGUE (fatigue), NAUSEA (nausea) and VACCINATION SITE PAIN (Arm sore at injection site). At the time of the report, ADVERSE DRUG REACTION (pretty serious side effects), PERIPHERAL SWELLING (severe pain in arm which was swollen up), MYALGIA (severe pain in arm which was swollen up / arm was painfull), PYREXIA (fever), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient experienced similar kind of adverse events on March 29 2021 and 23 APR 2021 to Tetanus vaccine. Treatment medication include Tylenol which did not help.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant follow-up appended
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Illness, Vomiting
Clinical narrative: he got sick; diarrhea; Throwing up; Head hurt; could not get out of bed after second dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (he got sick), DIARRHOEA (diarrhea), VOMITING (Throwing up), HEADACHE (Head hurt) and FATIGUE (could not get out of bed after second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (he got sick), DIARRHOEA (diarrhea), VOMITING (Throwing up), HEADACHE (Head hurt) and FATIGUE (could not get out of bed after second dose). At the time of the report, ILLNESS (he got sick), DIARRHOEA (diarrhea), VOMITING (Throwing up), HEADACHE (Head hurt) and FATIGUE (could not get out of bed after second dose) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Non significant followup recieved report added On 06-Aug-2021: The follow up document was received and had non significant information
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia
Clinical narrative: Numbness of the tongue; Tingling of the fingers; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Numbness of the tongue) and PARAESTHESIA (Tingling of the fingers) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (Numbness of the tongue) and PARAESTHESIA (Tingling of the fingers). At the time of the report, HYPOAESTHESIA ORAL (Numbness of the tongue) and PARAESTHESIA (Tingling of the fingers) outcome was unknown. Not Provided          No concomitant product was reported. No treatment information was reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: He experienced a fever of 100 degrees F; He experienced body aches; He experienced soreness of the arm at the injection site; He experienced swelling of the arm at the injection site; He experienced headache; He experienced tiredness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (He experienced headache), FATIGUE (He experienced tiredness), PYREXIA (He experienced a fever of 100 degrees F), MYALGIA (He experienced body aches) and VACCINATION SITE PAIN (He experienced soreness of the arm at the injection site) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included No adverse event. Concomitant products included METFORMIN, GLIPIZIDE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), LISINOPRIL, VITAMIN D3 and CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (He experienced headache) and FATIGUE (He experienced tiredness). On 09-Apr-2021, the patient experienced PYREXIA (He experienced a fever of 100 degrees F), MYALGIA (He experienced body aches), VACCINATION SITE PAIN (He experienced soreness of the arm at the injection site) and VACCINATION SITE SWELLING (He experienced swelling of the arm at the injection site). At the time of the report, HEADACHE (He experienced headache), FATIGUE (He experienced tiredness), PYREXIA (He experienced a fever of 100 degrees F), MYALGIA (He experienced body aches), VACCINATION SITE PAIN (He experienced soreness of the arm at the injection site) and VACCINATION SITE SWELLING (He experienced swelling of the arm at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: TCR form attached on 24-may-2021 , Non - significant information , not interested to report details